AMH and ovarian dysfunction: In this context, the use of mesenchymal stem cells in the treatment of ovarian insufficiency resulting from chemotherapy in rats (Feng et al., 2020; Sen Halicioglu et al., 2022) was able to increase estrogen (E2) and anti-Müllerian hormone (AMH) concentrations.